Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor γ ligand, 15-Deoxy-Δ12,14-prostaglandin J2

Rachel Butler, Susan H. Mitchell, Donald J. Tindall, Charles Y F Young

Research output: Contribution to journalArticle

143 Citations (Scopus)

Abstract

15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) is a highly specific activator of the peroxisome proliferator-activated receptor γ (PPAR-γ). We investigated the effect of 15d-PGJ2 on three human prostate cancer cell lines, LNCaP, DU145, and PC-3. Western blotting demonstrated that PPAR-γ1 is expressed predominantly in untreated prostate cancer cells. Treatment with 15d-PGJ2 caused an increase in the expression of PPAR-γ2, whereas PPAR-γ1 remained at basal levels. PPARs α and β were not detected in these cells. Lack of lipid accumulation, increase in CCAAT/enhancer binding proteins (C/EBPs), or expression of aP2 mRNA indicated that adipocytic differentiation is not induced in these cells by 15d- PGJ'2. 15d-PGJ2 and other PPAR-γ activators induced cell death in all three cell lines at concentrations as low as 2.5 μM (similar to the K(d) of PPAR-γ for this ligand), coinciding with an accumulation of cells in the S-phase of the cell cycle. Activators for PPAR-α and β did not induce cell death. Staining with trypan blue and propidium iodide suggested that, although the plasma membrane appears intact by electron microscopy, disturbances are evident as early as 2 h after treatment. Mitochondrial transmembrane potentials are significantly reduced by 15d-PGJ2 treatment. In addition, treatment with 15d-PGJ2 resulted in cytoplasmic changes, which are indicative cell death.

Original languageEnglish (US)
Pages (from-to)49-61
Number of pages13
JournalCell Growth and Differentiation
Volume11
Issue number1
StatePublished - Jan 2000

Fingerprint

Peroxisome Proliferator-Activated Receptors
S Phase
Prostatic Neoplasms
Cell Death
Ligands
CCAAT-Enhancer-Binding Proteins
Cell Line
Trypan Blue
15-deoxy-delta(12,14)-prostaglandin J2
Propidium
Membrane Potentials
Electron Microscopy
Cell Cycle
Western Blotting
Cell Membrane
Staining and Labeling
Lipids
Messenger RNA

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor γ ligand, 15-Deoxy-Δ12,14-prostaglandin J2 . / Butler, Rachel; Mitchell, Susan H.; Tindall, Donald J.; Young, Charles Y F.

In: Cell Growth and Differentiation, Vol. 11, No. 1, 01.2000, p. 49-61.

Research output: Contribution to journalArticle

@article{762d84bfe45a473d9ea1ea6f9065c1e8,
title = "Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor γ ligand, 15-Deoxy-Δ12,14-prostaglandin J2",
abstract = "15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) is a highly specific activator of the peroxisome proliferator-activated receptor γ (PPAR-γ). We investigated the effect of 15d-PGJ2 on three human prostate cancer cell lines, LNCaP, DU145, and PC-3. Western blotting demonstrated that PPAR-γ1 is expressed predominantly in untreated prostate cancer cells. Treatment with 15d-PGJ2 caused an increase in the expression of PPAR-γ2, whereas PPAR-γ1 remained at basal levels. PPARs α and β were not detected in these cells. Lack of lipid accumulation, increase in CCAAT/enhancer binding proteins (C/EBPs), or expression of aP2 mRNA indicated that adipocytic differentiation is not induced in these cells by 15d- PGJ'2. 15d-PGJ2 and other PPAR-γ activators induced cell death in all three cell lines at concentrations as low as 2.5 μM (similar to the K(d) of PPAR-γ for this ligand), coinciding with an accumulation of cells in the S-phase of the cell cycle. Activators for PPAR-α and β did not induce cell death. Staining with trypan blue and propidium iodide suggested that, although the plasma membrane appears intact by electron microscopy, disturbances are evident as early as 2 h after treatment. Mitochondrial transmembrane potentials are significantly reduced by 15d-PGJ2 treatment. In addition, treatment with 15d-PGJ2 resulted in cytoplasmic changes, which are indicative cell death.",
author = "Rachel Butler and Mitchell, {Susan H.} and Tindall, {Donald J.} and Young, {Charles Y F}",
year = "2000",
month = "1",
language = "English (US)",
volume = "11",
pages = "49--61",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor γ ligand, 15-Deoxy-Δ12,14-prostaglandin J2

AU - Butler, Rachel

AU - Mitchell, Susan H.

AU - Tindall, Donald J.

AU - Young, Charles Y F

PY - 2000/1

Y1 - 2000/1

N2 - 15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) is a highly specific activator of the peroxisome proliferator-activated receptor γ (PPAR-γ). We investigated the effect of 15d-PGJ2 on three human prostate cancer cell lines, LNCaP, DU145, and PC-3. Western blotting demonstrated that PPAR-γ1 is expressed predominantly in untreated prostate cancer cells. Treatment with 15d-PGJ2 caused an increase in the expression of PPAR-γ2, whereas PPAR-γ1 remained at basal levels. PPARs α and β were not detected in these cells. Lack of lipid accumulation, increase in CCAAT/enhancer binding proteins (C/EBPs), or expression of aP2 mRNA indicated that adipocytic differentiation is not induced in these cells by 15d- PGJ'2. 15d-PGJ2 and other PPAR-γ activators induced cell death in all three cell lines at concentrations as low as 2.5 μM (similar to the K(d) of PPAR-γ for this ligand), coinciding with an accumulation of cells in the S-phase of the cell cycle. Activators for PPAR-α and β did not induce cell death. Staining with trypan blue and propidium iodide suggested that, although the plasma membrane appears intact by electron microscopy, disturbances are evident as early as 2 h after treatment. Mitochondrial transmembrane potentials are significantly reduced by 15d-PGJ2 treatment. In addition, treatment with 15d-PGJ2 resulted in cytoplasmic changes, which are indicative cell death.

AB - 15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) is a highly specific activator of the peroxisome proliferator-activated receptor γ (PPAR-γ). We investigated the effect of 15d-PGJ2 on three human prostate cancer cell lines, LNCaP, DU145, and PC-3. Western blotting demonstrated that PPAR-γ1 is expressed predominantly in untreated prostate cancer cells. Treatment with 15d-PGJ2 caused an increase in the expression of PPAR-γ2, whereas PPAR-γ1 remained at basal levels. PPARs α and β were not detected in these cells. Lack of lipid accumulation, increase in CCAAT/enhancer binding proteins (C/EBPs), or expression of aP2 mRNA indicated that adipocytic differentiation is not induced in these cells by 15d- PGJ'2. 15d-PGJ2 and other PPAR-γ activators induced cell death in all three cell lines at concentrations as low as 2.5 μM (similar to the K(d) of PPAR-γ for this ligand), coinciding with an accumulation of cells in the S-phase of the cell cycle. Activators for PPAR-α and β did not induce cell death. Staining with trypan blue and propidium iodide suggested that, although the plasma membrane appears intact by electron microscopy, disturbances are evident as early as 2 h after treatment. Mitochondrial transmembrane potentials are significantly reduced by 15d-PGJ2 treatment. In addition, treatment with 15d-PGJ2 resulted in cytoplasmic changes, which are indicative cell death.

UR - http://www.scopus.com/inward/record.url?scp=0033950982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033950982&partnerID=8YFLogxK

M3 - Article

C2 - 10672903

AN - SCOPUS:0033950982

VL - 11

SP - 49

EP - 61

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 1

ER -